![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Genet. , 08 June 2023
Sec. Computational Genomics
Volume 14 - 2023 | https://doi.org/10.3389/fgene.2023.1180076
This article is a correction to:
Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
A Corrigendum on
Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
by Wu W, Liu S, Tian L, Li C, Jiang Y, Wang J, Lv Y, Guo J, Xing D, Zhai Y, Sun H, Li Y, Zhang L, He X, Luo K, Zhan H and Zhao Z (2023). Front. Genet. 13:1092678. doi: 10.3389/fgene.2022.1092678
In the published article, there was an error in Affiliation(s) “3”. Instead of “Department of Gastroenterology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Jinan, China”, it should be “Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.”
Also, for author “Hongjie Zhan”, the city in the affiliation is corrected from “Jinan” to “Tinajin” and its was renumbered to 4: “Department of Gastroenterology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: DLBCL, microtube-associated genes, prognostic model, targeting therapy, TMEM63A
Citation: Wu W, Liu S, Tian L, Li C, Jiang Y, Wang J, Lv Y, Guo J, Xing D, Zhai Y, Sun H, Li Y, Zhang L, He X, Luo K, Zhan H and Zhao Z (2023) Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction. Front. Genet. 14:1180076. doi: 10.3389/fgene.2023.1180076
Received: 05 March 2023; Accepted: 18 April 2023;
Published: 08 June 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Wu, Liu, Tian, Li, Jiang, Wang, Lv, Guo, Xing, Zhai, Sun, Li, Zhang, He, Luo, Zhan and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hongjie Zhan, aG9uZ2ppZXpoYW5AMTYzLmNvbQ== Zhigang Zhao, enpoYW8wMUB0bXUuZWR1LmNu
†These authors share first authorship
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.